Andrea Tresoldi
Overview
Explore the profile of Andrea Tresoldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cazzaniga G, Mori M, Griego A, Scarpa E, Moschetti G, Muzzioli S, et al.
J Med Chem
. 2025 Mar;
68(5):5312-5332.
PMID: 40029993
The urgent need for safer and innovative antitubercular agents remains a priority for the scientific community. In pursuit of this goal, we designed and evaluated novel 5-phenylfuran-2-carboxylic acid derivatives targeting...
2.
Cazzaniga G, Tresoldi A, Gelain A, Meneghetti F, Mori M, Villa S
Chem Biodivers
. 2024 Jan;
21(2):e202301729.
PMID: 38241063
Nature-derived products, like juices and peel extracts of fruits and vegetables, have emerged in recent years as interesting and sustainable alternatives to traditional solvents in several synthetic applications. Herein, we...
3.
Mori M, Cocorullo M, Tresoldi A, Cazzaniga G, Gelain A, Stelitano G, et al.
Eur J Med Chem
. 2024 Jan;
265:116073.
PMID: 38169270
Blocking iron uptake and metabolism has been emerging as a promising therapeutic strategy for the development of novel antimicrobial compounds. Like all mycobacteria, M. abscessus (Mab) has evolved several countermeasures...
4.
Mori M, Stelitano G, Cazzaniga G, Gelain A, Tresoldi A, Cocorullo M, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839823
Targeting pathogenic mechanisms, rather than essential processes, represents a very attractive approach for the development of new antimycobacterial drugs. In this context, iron acquisition routes have recently emerged as potentially...